cabotegravir + rilpivirine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for cabotegravir + rilpivirine, covering 2026-02-11 to 2026-02-11. Get the full timeline:
Most recent: Clinical Trial Update: Study of B/F/TAF in Participants Switching From CAB + RPV to B/F/TAF for HIV-1 Infection (EMPOWER) [Phase 4]